Myovant Sciences Ltd. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Myovant Sciences Ltd. had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $37.53 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2023-01-26
- 2022-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $37.53M.
- 2022-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $39.25M.
- 2022-06-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $25.85M.
- 2022-03-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $19.88M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2022-12-31 | $37.53M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $39.25M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $25.85M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $19.88M 10-Q · filed 2023-01-26 |
| 2021-03-31 | $1.39M 10-K · filed 2022-05-11 |